A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma - Giesen, Nicola; Chatterjee, Manik; Scheid, Christof; Poos, Alexandra; Besemer, Britta; Miah, Kaya; Benner, Axel; Becker, Nicole; Moehler, Thomas; Metzler, Ivana; Khandanpour, Cyrus; Seidel-Glätzer, Andrea; et al. (Blood, 2023)
Gesehen am 15.06.2023